The Investor Globe

  Home   |  Business   |  Personal Finance   |  Gold   |  World   |  USA   |  China   |  India   |  Middle East   |  Bitcoin   |  Techno   |  Blogs   |  M & A   |  IPO

Top Stories on AstraZeneca

AstraZeneca sales hit hard by generic competition - Reuters

LONDON (Reuters) - AstraZeneca's sales tumbled 21 percent in the second quarter, punished by generic competition to its best-selling antipsychotic medicine Seroquel and pressure on health spending in Europe. Continued supply chain disruptions ...

AstraZeneca Leads Drugmakers With European Sales Decline - Businessweek

AstraZeneca Plc (AZN), Roche Holding AG (ROG) and Sanofi (SAN) reported declining revenue in Europe as government austerity measures push down prices and make it harder for some customers to pay their bills. Sales in Western Europe fell 20 ...

AstraZeneca PLC AZN Transaction in Own Shares - Bloomberg

AstraZeneca PLC (AZN) - Transaction in Own Shares RNS Number : 7438I AstraZeneca PLC 30 July 2012 ? REPURCHASE OF SHARES IN ASTRAZENECA PLC Further to the announcement of its irrevocable, non-discretionary share repurchase programme ...

AstraZeneca PLC AZN Notice of Results - Bloomberg

AstraZeneca PLC (AZN) - Notice of Results RNS Number : 3966I AstraZeneca PLC 25 July 2012 ? AstraZeneca Second Quarter & Half Year Results 2012 Tomorrow, Thursday, 26 July 2012, AstraZeneca will release second quarter and half year ...

AstraZeneca PLC (AZN) : Company Profile and SWOT Analysis - new company profile report - Transworld News

AstraZeneca PLC (AstraZeneca) discovers, develops, produces and markets a broad range of biologics, prescription pharmaceuticals and vaccines. The company manufactures therapeutics for the treatment of diseases such as cancer, cardiovascular ...

AstraZeneca profits dive on patent expiries - YAHOO!

Anglo-Swedish pharmaceuticals giant AstraZeneca said Thursday that second-quarter profits sank, hit by the expiry of key drug patents, tough conditions and competition from generic drugmakers. Earnings after taxation dived 24 percent to $1.61 billion (1.33 ...

AstraZeneca sales tumble on generic rivalry - Daily Telegraph

Britain?s second biggest pharmaceutical company saw revenues fall 21pc to $6.7bn (4.3bn) while profits tumbled 38pc to $1.76bn in the second quarter of the year, leaving half-year profits down by the same margin at $3.82bn pre-tax. The decline had been ...

AstraZeneca keeps outlook as earnings decline - Marketwatch

LONDON--AstraZeneca PLC (NYSE:AZN) Thursday stuck to its full-year earnings guidance despite reporting another slump in quarterly sales and profits, as patents on key drugs expire and governments in Europe and the U.S. squeeze prices. The U.K.'s ...
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
/script>
 

/script>
 
Blogspot logo    Latest Posts from Jim Rogers blog
Focus On Stocks That Are Not On The ETFs Radars
When The Bear Market Arrives...
The US Dollar Will Lose The Currency Reserve Status Fast
Investing: How To Be Successful
Gold Will Eventually Have An Epic Move Up
 
Blogspot logo    Latest Posts from Felix Zulauf blog
Felix Zulauf: Japan Will Be the Root Cause of the Next Global Crisis
Felix Zulauf Readies Hedge Fund With Son
FELIX ZULAUF: Stocks Remind Me Of Gold And They Could See A 'Quick And Painful Adjustment'
Felix Zulauf Recommended 7 Trades At Barron's Roundtable
Felix Zulauf's Yen for Japan
 
  Latest Posts from Mad Money 
Cramer?s Exec Cut: The benefits and dangers of advancing technology
Cramer Remix: The 2 distinct places investors should keep their cash
Cramer makes the bull case for including bonds in your portfolio
Cramer shares the best way to get your child excited about investing
Cramer: How compounding can help you double your money in 7 years
 
   Latest Posts from Fast Money
'Ugly correction' coming: Dennis Gartman
Your first trade for Tuesday
Retail terrified by EEM: Pro
Stock Pops & Drops: AOL, FEYE, JOSB & RYAAY
Second leg of bond rally: Pro
 
 Latest Posts from Bill Cara blog
Tables & Charts for Wednesday, Apr 17th, 2013
Bill Cara's Blog for Apr 17, 2013
Tables & Charts for Tuesday, Apr 16th, 2013
Bill Cara's Blog for Apr 16, 2013
Tables & Charts for Monday, Apr 15th, 2013
 
logo    Latest Posts from Kirk Report

Warning: MagpieRSS: Failed to parse RSS file. (XML_ERR_NAME_REQUIRED at line 1, column 2) in C:\Inetpub\vhosts\theinvestorglobe.com\httpdocs\rss_fetch.inc on line 414

Warning: array_slice() expects parameter 1 to be array, null given in C:\Inetpub\vhosts\theinvestorglobe.com\httpdocs\corporations-news.php on line 440

Warning: Invalid argument supplied for foreach() in C:\Inetpub\vhosts\theinvestorglobe.com\httpdocs\corporations-news.php on line 441
 
Blogspot logo    Latest Posts from Random Roger
Serious Retirement Downsizing
Planning Advice From True Experts
James Altucher is Right, Retirees Shouldn?t Own A Home
?You?ll Be Stone Dead In A Moment?
Rock You Like A Hurricane
 
  Home

  Business News
  Personal Finance
  World News
  U.S. News
  China News
  India News
  Middle East News
  Technology
  Blogs

  Mergers and Acquisitions
  IPO (initial Public Offering)
  Bernard Madoff
  Geneal Motors Bankruptcy
  Food prices crisis

  Sitemap
  Gold
  Silver
  Platinum
  Palladium
  Rhodium

         

               
                 Copyright Leaderglobe.